MolNFT v1 · #161226 · protein
Crystal structure of BH32 alkylated with the mechanistic inhibitor 2- bromoacetophenone
6Q7N: “Crystal structure of BH32 alkylated with the mechanistic inhibitor 2- bromoacetophenone”. X-ray diffraction, 1 ligand (AC0), 1 pocket (best druggability 0.79). MolNFT v1 #161226 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 6Q7N
- Type
- protein
- Length
- 230 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- BH32
- UniProt
- O58216
- Ligands
- AC0
- Pockets
- 1 · best druggability 0.79
Structure
x-ray diffraction · 1 distinct chain · 54% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | BH32 | protein | 230 | 54% helix, 15% strand | O58216 |
Ligands and binding sites
- AC0 · 1-phenylethanone · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 611 | 0.79 | 0.84 | 57 | AC0 |
Modifications
Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).
Compared structures
- 6Q7N · Crystal structure of BH32 alkylated with the mechanistic inhibitor 2-bromoacetophe · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O58216
- Elsewhere: RCSB PDB 6Q7N · PDBe 6Q7N · UniProt O58216
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.